Dr. Daniel Sass is a South African-trained doctor with a diverse background across clinical practice and health technology. He earned his medical degree from the University of the Witwatersrand and furthered his training in Emergency Medicine through the Colleges of Medicine of South Africa. He spent much of his clinical career on the frontlines of emergency departments in Cape Town, gaining firsthand insight into healthcare delivery under pressure.
In 2021, Daniel relocated to Israel to pursue an MBA in Technology, Entrepreneurship, and Innovation at Tel Aviv University. Prior to joining aMoon, he served as Director of Sales and Business Development at Pheno.AI, a company building the world’s deepest phenotype dataset of human health and disease to unlock the future of AI-driven precision medicine. There, he worked closely with the CEO and leadership team to scale the Human Phenotype Project globally.
Daniel is passionate about working at the intersection of health, technology, and business to improve human health at scale. At aMoon, he leverages his clinical and business background to evaluate late-stage investment opportunities for the firm’s Growth Fund. With a unique blend of medical and commercial expertise, he is driven by a deep commitment to improve human health at scale.
Health is also deeply personal for Daniel. A dedicated Ironman athlete, he has competed in numerous Ironmans, marathons, and ultramarathons across Africa, Europe, and the Middle East—reflecting the same endurance and discipline he brings to his professional pursuits.
